Navigation Links
Biopharm Insight Hosts Educational Webinar Ahead of American Society of Hematology Conference Next Month
Date:11/13/2013

Norwood, MA (PRWEB) November 13, 2013

BioPharm Insight, a division of Infinata, will host an educational webinar to unveil highlights ahead of the American Society of Hematology (ASH) Annual Conference next month. The ASH Conference takes place December 7-10 in New Orleans.

Webinar: BioPharm Insight’s Pre-ASH Crash Course
Speaker: Juliana Wexler, Oncology Reporter
Date & Time: November 21, 10:00 AM EST
Register: http://goo.gl/5ij5j9

The webinar will cover:

  •     Celgene’s Revlimid - MM-020 and MM-015 trial results in newly-diagnosed multiple myeloma (MM)
  •     Array Biopharma’s ARRY-520 Phase Ib results in relapsed/refractory MM
  •     Antibodies in MM, including Genmab/Janssen’s daratumumab
  •     Ambit BioSciences’ quizartinib in AML
  •     MDS update with Array’s ARRY-614, Astex's SGI-110
  •     HDAC inhibitors development for MDS and MM
  •     B-cell inhibitors in CLL -- Gilead’s idelalisib, Pharmacyclics’ ibrutinib, Infinity’s IPI-145

Juliana Wexler specializes in cancer coverage for BioPharm Insight. Previously she was an HIV public health advocate at Jacobi Medical Center in New York, where she was involved in both research and recruiting participants for clinical trials. She has also been a research assistant at both Columbia University, as well as the University of Michigan. Juliana graduated with an individualized Bachelor’s in Health Care and Health Disparities from the University of Michigan.

About BioPharm Insight
BioPharm Insight is part of Infinata, a Financial Times Group company, and a leading provider of business intelligence solutions which also include BioPharm Clinical™, High Net Worth Insight™ and wealthmonitor™. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com.

About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.

Business Inquiries: Holly Burke, hburke[at]infinata[dot]com, 781-619-0131
Media Inquiries: Brenda Nashawaty, Brenda[at]nashawaty[dot]com, 617-688-3253

Read the full story at http://www.prweb.com/releases/2013/11/prweb11325293.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Biopharmaceuticals - A Global Market Overview
2. Biopharm Insight’s Respiratory Disease Report Highlights Key Drugs Coming Up for Approval or in Late-Stage Development
3. Mass Spectrometry Marketplace Discussed by Biopharm Reports in In-demand Research Study Available at MarketPublishers.com
4. World Antibiotic Resistance Market Saw Big Changes in Last Five Years, According to Biopharm Reports Study Available at MarketPublishers.com
5. Therapure Biopharma Inc. Awarded US Government Contract for Development of Anti-Nerve Gas Agent
6. Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in New Research Report at ReportsnReports.com
7. BioPharm Systems Unveils Study Data Mapper to Simplify the Preparation and Reporting of Clinical Data
8. Nine Lives Media Names BioPharm Systems to the MSPmentor 501
9. BioPharm Systems to Host Webinar on Clinical Trial Supply Management with Siebel CTMS
10. BioPharm Systems to Host Webinar on Using iHelp in Oracle’s Siebel Clinical Trial Management System
11. BioPharm Systems Named to the 2012 Lead411 Technology 200 List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/7/2020)... (PRWEB) , ... April 07, 2020 , ... ... pandemic, water utilities are swiftly employing plans to prevent service disruptions and assist ... conducted by the American Water Works Association (AWWA). , Ninety-seven percent ...
(Date:4/5/2020)... ... 04, 2020 , ... Visiun, the leader in laboratory analytics, ... of COVID-19 testing that must be submitted to HHS and FEMA on a ... all hospitals report data on COVID-19 testing performed by “in-house” laboratories (academic/university/hospital) daily ...
(Date:4/2/2020)... ... April 02, 2020 , ... ... An FDAnews Webinar, Tuesday April 7, 2020, 1:30-3:00 p.m. EDT, https://www.fdanews.com/cdssoftwareregulation ... regulation of AI used to guide clinical management of the Coronavirus.* , Is ...
(Date:4/2/2020)... ... ... Since the onset of the COVID-19 pandemic, there hasn’t yet been a clear ... founder Yaniv Nissim has stepped up to the plate to address this gap. Nissim, ... standards for delivering food during this time of COVID-19 so that consumers can feel ...
(Date:4/1/2020)... ... April 02, 2020 , ... Medical Device Change Management, An ... https://www.fdanews.com/mdchangemanagement , What change management method should one be using for a ... dependent on the type of change. Is it due to post-market design change, production ...
Breaking Medicine News(10 mins):
(Date:4/5/2020)... ... April 04, 2020 , ... This week, the Arizona-based ... initiative, tasking ambassadors, support group leaders, board members and staff with calling hundreds ... with a movement disorder can be so isolating and PMD Alliance remains committed ...
(Date:4/5/2020)... ... April 04, 2020 , ... As ... arise for medical supplies, diagnostics, and treatments. Shortages of such supplies are plaguing ... , Tran & Associates supports the fight against COVID-19 and encourages ...
(Date:4/2/2020)... ... ... Planning an Audit Response:, How to Handle MDSAP Findings, An FDAnews Management ... spotted by a notified body during an audit does happen. What is the best ... pressure with only 15 days to craft a response to the auditing body. , ...
Breaking Medicine Technology: